144 ·Filed Jun 2, 2026

VCEL

Vericel Corp
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago SEC0001959173-26-004258
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

The proposed sale is small in absolute and relative terms, unlikely to move the stock. Monitor for any follow-on Form 4 filings to confirm execution, but no immediate trading action is warranted.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
VCEL ▲ +23.19% at T+60d
NEUTRAL call ✓ call won +23.19% · α vs SPY +22.08% · entry $34.45 → $42.44
Entry anchored
Jun 2, 02:39 PM ET
via exchange tick
T+1d
+0.84%
call +0.84% · α +1.54%
$34.74
settled 4mo ago
T+5d
+7.49%
call +7.49% · α +10.45%
$37.03
settled 4mo ago
T+20d
+31.06%
call +31.06% · α +32.62%
$45.15
settled 3mo ago
T+60d
+23.19%
call +23.19% · α +22.08%
$42.44
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Jonathan M. Hopper, an officer of Vericel Corp, filed a Form 144 on June 2, 2026, indicating intent to sell 4,375 shares of common stock with an estimated market value of $153,125. The shares were acquired via an option grant dated February 6, 2019, and the sale is planned as a cash transaction through Fidelity Brokerage Services. This is a relatively small sale relative to the company's $1.7B market cap and follows a pattern of insider selling (5 sales totaling $588K in the past 30 days), but the dollar amount is modest and does not signal a material change in outlook.

Key Facts

  • Insider: Jonathan M. Hopper, an officer of Vericel Corp
  • Proposed sale: 4,375 shares of common stock
  • Estimated value: $153,125 (based on $35.00/share approximate price)
  • Shares acquired via option grant dated February 6, 2019
  • Sale intended as cash transaction through Fidelity Brokerage Services LLC
  • Filing date: June 2, 2026
  • Recent insider activity: 5 sales totaling $588K in the past 30 days

Financial Impact

Proposed sale of $153,125 in shares, representing approximately 0.009% of market cap

dilution

Risk Factors

  • Insider selling pattern may continue, but current filing is too small to be material
  • No other material events or financial data in this filing to assess broader risk

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-004258
Document: 0001959173-26-004258-index.html0001959173-26-004258
Document: 0001959173-26-004258.txt0001959173-26-004258
12 reports for VCEL
Performance horizon
50% Hit rate 2 of 4 directional calls best @ T+60▲ +31.08%May 7, 2026
Filters
Rows
Reports for VCEL — sortable, filterable
TypeNow
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$45.36 $40.89▼ −9.85%▼ −9.25%$39.89 (−12.06%)
Jul 30, 2026
9w ago
8-K
BULLISH ★ 6/10
$47.61 $41.18▼ −13.51%▼ −17.47%$39.89 (−16.22%)
Jul 16, 2026
11w ago
Press Release
NEUTRAL ★ 2/10
$47.81 $44.54▼ −6.84%▼ −10.46%$39.89 (−16.57%)
Jun 30, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$45.15 $46.62▲ +3.26%▲ +5.44%$39.89 (−11.65%)
Jun 2, 2026
17w ago
144
NEUTRAL ★ 2/10
$34.45 $45.15▲ +31.06%▲ +32.62%$39.89 (+15.79%)
May 15, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$34.87 $38.46▲ +10.30%▲ +8.71%$39.89 (+14.40%)
May 7, 2026
21w ago
8-K
BULLISH ★ 7/10
$35.13 $34.74▼ −1.11%▼ −4.25%$39.89 (+13.55%)
May 7, 2026
21w ago
Press Release
BULLISH ★ 8/10
$35.13 $34.74▼ −1.11%▼ −4.25%$39.89 (+13.55%)
Apr 23, 2026
23w ago
Press Release
NEUTRAL ★ 3/10
$34.40 $35.40▲ +2.91%▼ −1.73%$39.89 (+15.96%)
Mar 19, 2026
28w ago
DEFA14A
NEUTRAL ★ 3/10
$32.74 $35.68▲ +8.98%▲ +1.36%$39.89 (+21.84%)
Showing 10 of 12

US Market Status

Market Open — Closes in 1h 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access